TF and neoplasm: Some of these gaps are technical—for example, can we standardize our definition of CSC, and consistently apply the most stringent criteria for “stemness,” which is the ability for a small number of tumor cells to give rise to an STS, rather than rely on descriptions of stemness TF or cell surface marker expression?